MARKET

AMRX

AMRX

Amneal Pharmaceuticals Inc
NASDAQ
12.96
-0.24
-1.82%
After Hours: 12.96 0 0.00% 19:29 01/09 EST
OPEN
13.19
PREV CLOSE
13.20
HIGH
13.31
LOW
12.93
VOLUME
1.51M
TURNOVER
--
52 WEEK HIGH
13.49
52 WEEK LOW
6.69
MARKET CAP
4.07B
P/E (TTM)
785.45
1D
5D
1M
3M
1Y
5Y
1D
KeifeRx LRRK2 Parkinson’s Collaboration Might Change The Case For Investing In Amneal Pharmaceuticals (AMRX)
Simply Wall St · 1d ago
Amneal Pharmaceuticals, KeifeRx enter research collaboration, option agreement
TipRanks · 1d ago
KeifeRx Enters Into A Research Collaboration And Option Agreement With Amneal Pharmaceuticals To Support The Pre-IND Development Of KFRX06
Benzinga · 1d ago
KEIFERX ANNOUNCES RESEARCH COLLABORATION AND OPTION AGREEMENT WITH AMNEAL PHARMACEUTICALS TO ADVANCE KFRX06, A BRAIN-PENETRANT LRRK2 PROGRAM FOR PARKINSON’S DISEASE
Reuters · 1d ago
KEIFERX: FINANCIAL TERMS OF AGREEMENT WERE NOT DISCLOSED
Reuters · 1d ago
Amneal Pharmaceuticals Partners with KeifeRx to Advance LRRK2 Inhibitor for Parkinson’s Disease
Reuters · 1d ago
A Look At Amneal Pharmaceuticals (AMRX) Valuation As Analyst Optimism And Revenue Outlook Support Recent Momentum
Simply Wall St · 2d ago
Flu medication is in short supply in part of U.S. as cases soar
Seeking Alpha · 2d ago
More
About AMRX
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Webull offers Amneal Pharmaceuticals Inc stock information, including NASDAQ: AMRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRX stock methods without spending real money on the virtual paper trading platform.